Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Molecular Pharmacology

• Publication date

  2017-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/mol.116.105544PMID 27777271PMCID PMC5198512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy

  2015influential reference
• Solute Carrier Family of the Organic Anion-Transporting Polypeptides 1A2– Madin-Darby Canine Kidney II: A Promising In Vitro System to Understand the Role of Organic Anion-Transporting Polypeptide 1A2 in Blood-Brain Barrier Drug Penetration

  2015cited by this paper
• Contribution of Hepatic Organic Anion-Transporting Polypeptides to Docetaxel Uptake and Clearance

  2015influential reference
• Expression of organic anion-transporting polypeptide 1A2 and organic cation transporter 6 as a predictor of pathologic response to neoadjuvant chemotherapy in triple negative breast cancer

  2014cited by this paper
• In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters

  2014influential reference
• Impact of genetic variation in OATP transporters to drug disposition and response.

  2013cited by this paper
• Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years

  2013cited by this paper
• Enhanced expression of organic anion transporting polypeptides (OATPs) in androgen receptor-positive prostate cancer cells: possible role of OATP1A2 in adaptive cell growth under androgen-depleted conditions.

  2012cited by this paper
• Influence of Polymorphic OATP1B-Type Carriers on the Disposition of Docetaxel

  2012cited by this paper
• Environmental and Genetic Factors Affecting Transport of Imatinib by OATP1A2

  2011cited by this paper
• Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport.

  2011cited by this paper
• Pharmacokinetics of anti-cancer drugs used in breast cancer chemotherapy.

  2010cited by this paper
• High Impact of Oatp1a/1b Transporters on In Vivo Disposition of the Hydrophobic Anticancer Drug Paclitaxel

  2010cited by this paper
• HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms

  2010cited by this paper
• Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs.

  2010cited by this paper
• Different expression patterns of organic anion transporting polypeptides in osteosarcomas, bone metastases and aneurysmal bone cysts.

  2009cited by this paper
• Targeted Disruption of Murine Organic Anion-Transporting Polypeptide 1b2 (oatp1b2/Slco1b2) Significantly Alters Disposition of Prototypical Drug Substrates Pravastatin and Rifampin

  2008cited by this paper
• Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer.

  2008cited by this paper
• Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family

  2008cited by this paper
• Role of anthracyclines in the era of targeted therapy

  2007cited by this paper
• Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans

  2007cited by this paper
• Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps.

  2006cited by this paper
• Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice

  2006cited by this paper
• Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma.

  2006cited by this paper
• TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS)

  2005cited by this paper
• Characterization of the organic cation transporter SLC22A16: a doxorubicin importer.

  2005cited by this paper
• Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2)

  2005influential reference
• Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel

  2005cited by this paper
• Suppression of Cell Proliferation by Inhibition of Estrone-3-Sulfate Transporter in Estrogen-Dependent Breast Cancer Cells

  2005cited by this paper
• Ethnicity-dependent Polymorphism in Na+-taurocholate Cotransporting Polypeptide (SLC10A1) Reveals a Domain Critical for Bile Acid Substrate Recognition*

  2004cited by this paper
• Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties

  2004cited by this paper
• Involvement of Estrone-3-Sulfate Transporters in Proliferation of Hormone-Dependent Breast Cancer Cells

  2004cited by this paper
• The superfamily of organic anion transporting polypeptides.

  2003cited by this paper
• Pharmacokinetic-Pharmacodynamic Relationships of the Anthracycline Anticancer Drugs

  2002cited by this paper
• Identification of OCT6 as a novel organic cation transporter preferentially expressed in hematopoietic cells and leukemias.

  2002cited by this paper
• Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man.

  2002cited by this paper
• LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

  2001cited by this paper
• Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver.

  2001cited by this paper
• Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide*

  2000influential reference
• The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice.

  2000cited by this paper
• Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.

  2000cited by this paper
• A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane.

  2000influential reference
• A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.

  1999cited by this paper
• The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin.

  1999cited by this paper
• The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

  1998cited by this paper
• Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.

  1997cited by this paper
• Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver.

  1995cited by this paper
• The anthracyclines: will we ever find a better doxorubicin?

  1992cited by this paper
• Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporters.

  1991cited by this paper
• Expression of a multidrug-resistance gene in human tumors and tissues.

  1987cited by this paper

• Role of solute carrier transporters in the biodistribution and toxicity of chemotherapeutic drugs.

  2026cites this paper
• Preparation and Characterization of a Glutathione-Responsive Doxorubicin Prodrug Modified by 2-Nitrobenzenesulfonamide Group—Its Selective Cytotoxicity Toward Cells with Enhanced Glutathione Production

  2025influential citation
• Activation of pregnane X receptor-organic anion transporting polypeptide 1a/b /P-glycoprotein/multidrug resistance protein 2 axis mediates the accelerated blood and liver clearance of PEGylated liposomes.

  2025cites this paper
• Multifactorial etiology of progressive supranuclear palsy (PSP): the genetic component

  2025cites this paper
• Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice.

  2024cites this paper
• Exploring Bile Acid Transporters As Key Players In Cancer Development And Treatment: Evidence From Preclinical And Clinical Studies.

  2024cites this paper
• Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition.

  2024cites this paper
• Free drug and ROS-responsive nanoparticle delivery of synergistic doxorubicin and olaparib combinations to triple negative breast cancer models.

  2024cites this paper
• Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming.

  2023cites this paper
• The fluorescence‐based competitive counterflow assay developed for organic anion transporting polypeptides 1A2, 1B1, 1B3 and 2B1 identifies pentamidine as a selective OATP1A2 substrate

  2023cites this paper
• Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.

  2023cites this paper
• Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia

  2022cites this paper
• Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives

  2022cites this paper
• Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4

  2022cites this paper
• Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective

  2022cites this paper
• The role of OATP1B1 and OATP1B3 transporter polymorphisms in drug disposition and response to anticancer drugs: a review of the recent literature

  2022cites this paper
• Using a competitive counterflow assay to identify novel cationic substrates of OATP1B1 and OATP1B3

  2022cites this paper
• Examination of the emerging role of transporters in the assessment of nephrotoxicity

  2022cites this paper
• The role of OATP1A1 in cholestasis and drug-induced toxicity: a systematic review

  2022cites this paper
• Why Do Dietary Flavonoids Have a Promising Effect as Enhancers of Anthracyclines? Hydroxyl Substituents, Bioavailability and Biological Activity

  2022influential citation
• Pharmacogenomics of celiprolol – evidence for a role of P‐glycoprotein and organic anion transporting polypeptide 1A2 in celiprolol pharmacokinetics

  2021cites this paper
• New prodrugs and analogs of the phenazine 5,10-dioxide natural products iodinin and myxin promote selective cytotoxicity towards human acute myeloid leukemia cells

  2021cites this paper
• Expression and Functional Contribution of Different Organic Cation Transporters to the Cellular Uptake of Doxorubicin into Human Breast Cancer and Cardiac Tissue

  2021cites this paper
• Molecular Properties of Drugs Handled by Kidney OATs and Liver OATPs Revealed by Chemoinformatics and Machine Learning: Implications for Kidney and Liver Disease

  2021cites this paper
• Synthesis, cytotoxicity evaluation, and molecular modeling studies of 2,N10-substituted acridones as DNA-intercalating agents

  2020cites this paper
• Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver.

  2020cites this paper
• Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.

  2020cites this paper
• Gender Differences in the Effect of Calcitriol on the Body Disposition and Excretion of Doxorubicin in Mice

  2020cites this paper
• Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

  2020cites this paper
• Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?

  2020cites this paper
• Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment

  2020cites this paper
• Basolateral Plasma Membrane Organic Anion Transporters

  2020cites this paper
• Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology

  2019influential citation
• Brain Delivery of a Potent Opioid Receptor Agonist, Biphalin during Ischemic Stroke: Role of Organic Anion Transporting Polypeptide (OATP)

  2019cites this paper
• Drug transporters and anthracycline-induced cardiotoxicity.

  2018cites this paper
• Transport of salvianolic acid B via the human organic anion transporter 1B1 in the liver

  2018cites this paper
• Characterization of the membrane transporter OATP1A2 activity towards different classes of drugs

  2017cites this paper
• Chemoresistance and chemosensitization in cholangiocarcinoma.

  2017cites this paper